MK-8245是一种靶向作用于肝脏的stearoyl-CoA desaturase (SCD)（硬脂酰辅酶A去饱和酶）抑制剂，作用于人类SCD1时，IC50为1 nM，作用于大鼠和小鼠SCD1时，IC50为3 nM，具有抗糖尿病和抗高脂血症作用。Phase 2。 MK-8245 is an liver-targeting inhibitor of stearoyl-CoA desaturase (SCD) with IC50 of 1 nM for human SCD1 and 3 nM for both rat SCD1 and mouse SCD1, with anti-diabetic and anti-dyslipidemic efficacy. Phase 2.